Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
German mid-sized firms gloomy on outlook, survey finds - 2German Cabinet advances bill to cut greenhouse emissions from fuels
- 3Manual for Tracking down One of a kind Store Inns
- 4Lula’s former human rights minister formally accused of sexual misconduct
- 5How Mars' ancient lakes grew shields of ice to stay warm as the Red Planet froze
- Flu cases are rising with a strain that makes older people sicker
- Instructions to Pick the Right Tires for Your Slam 1500.
- Ukraine Now Using Drone Boats To Attack Russian Riverine Targets
- The Century Coupe Could Be Toyota’s Most Ambitious Car Since the LFA
- Russia confirms 16 Cameroonian soldiers killed in Ukraine war
- New India programme supports tribal families hosting tourists
- Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
- Plane Passenger Allegedly Includes ‘Bomb Threat’ in Hotspot Network Name, Forces Flight to Make Emergency Landing
- Blue Origin's next space tourism flight will break new ground for people with disabilities
